Titlebook: Stroke Revisited: Diabetes in Stroke; Seung-Hoon Lee,Dong-Wan Kang Book 2021 The Editor(s) (if applicable) and The Author(s), under exclus

Haphazard

Hyperglycemia in Acute Strokeon is a multistep process mediated by various brain and immune cells. Inflammatory responses exaggerate the pathologies of ischemic stroke by promoting neuronal cell death and brain edema. Hyperglycemia is common in the acute stage of stroke, and this condition can promote brain inflammation and wor

故意

Clinical Impact of Diabetes Mellitus in Cardiovascular Diseasesases. Hypertension is the most common cause of cardiovascular diseases and it is one of the most common comorbidity in diabetic patients. The risk of cardiovascular disease is higher in people with concomitant hypertension and diabetes compared to those with hypertension or diabetes alone. Diabetes

myalgia

Epidemiology of Stroke Patients with Diabetesble the risk of stroke than those without diabetes. On the other hand, an acute stroke gives rise to abnormalities in the glucose metabolism that, in turn, affects its outcome..Diabetes mellitus can affect blood vessels in various parts of the human body. It is one of the most important risk factors

insomnia

名詞

一再煩擾

能量守恒

鐵塔等

Dipeptidyl Peptidase-4 Inhibitorsat specifically bind to the catalytic domain of DPP-4, which consequently prevents the enzymatic inactivation of incretin hormones (glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide). By increasing the circulating levels of active incretin hormones, DPP-4 inhibitors stimulate

BAIL

清晰

Glucagon-like Peptide-1 Receptor Agonistse first GLP-1RA, was approved in 2005. GLP-1 is a peptide hormone secreted by L cells of the small intestine in response to nutrients. GLP-1 presents a glucose-lowering effect via their insulinotropic action on pancreatic β-cells. In addition to their insulinotropic effect, GLP-1 also has pleiotropi